RG 7166

Drug Profile

RG 7166

Alternative Names: RG-7166

Latest Information Update: 12 Nov 2016

Price : $50

At a glance

  • Originator Roche
  • Class Antidepressants
  • Mechanism of Action Adrenergic uptake inhibitors; Dopamine uptake inhibitors; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Major depressive disorder

Most Recent Events

  • 01 Feb 2012 Discontinued - Phase-I for Major depressive disorder (unspecified route)
  • 31 Dec 2009 Phase-I clinical trials in Depression (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top